{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T09:38:20Z","timestamp":1696930700836},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,9,29]],"date-time":"2013-09-29T00:00:00Z","timestamp":1380412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00262-013-1478-7","type":"journal-article","created":{"date-parts":[[2013,9,28]],"date-time":"2013-09-28T14:53:27Z","timestamp":1380380007000},"page":"1723-1732","source":"Crossref","is-referenced-by-count":7,"title":["The immunogenicity of a novel cytotoxic T lymphocyte epitope from tumor antigen PL2L60 could be enhanced by 4-chlorophenylalanine substitution at position 1"],"prefix":"10.1007","volume":"62","author":[{"given":"Ran-ran","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-ming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-xia","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-jie","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,29]]},"reference":[{"key":"1478_CR1","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/sj.leu.2404787","volume":"21","author":"JH Kessler","year":"2007","unstructured":"Kessler JH, Melief CJ (2007) Identification of T-cell epitopes for cancer immunotherapy. Leukemia 21:1859\u20131874","journal-title":"Leukemia"},{"key":"1478_CR2","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.4049\/jimmunol.170.9.4862","volume":"170","author":"A Uenaka","year":"2003","unstructured":"Uenaka A, Hirano Y, Hata H et al (2003) Cryptic CTL epitope on a murine sarcoma Meth A generated by exon extension as a novel mechanism. J Immunol 170:4862\u20134868","journal-title":"J Immunol"},{"key":"1478_CR3","author":"H Shen","year":"2012","unstructured":"Shen H, Shao HW, Chen XH et al (2012) Identification of a novel HLA-A2-restricted mutated Survivin epitope and induction of specific anti-HCC CTLs that could effectively cross-recognize wild-type Survivin antigen. Cancer Immunol Immunother. doi: 10.1007\/s00262-012-1323-4","journal-title":"Cancer Immunol Immunother"},{"key":"1478_CR4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc2355","volume":"8","author":"SA Rosenberg","year":"2008","unstructured":"Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME (2008) Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 8:299\u2013308","journal-title":"Nat Rev Cancer"},{"key":"1478_CR5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1126\/science.1100369","volume":"305","author":"JN Blattman","year":"2004","unstructured":"Blattman JN, Greenberg PD (2004) Cancer immunotherapy: a treatment for the masses. Science 305:200\u2013205. doi: 10.1126\/science.1100369305\/5681\/200","journal-title":"Science"},{"key":"1478_CR6","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.4049\/jimmunol.174.11.6716","volume":"174","author":"A Bredenbeck","year":"2005","unstructured":"Bredenbeck A, Losch FO, Sharav T, Eichler-Mertens M, Filter M, Givehchi A, Sterry W, Wrede P, Walden P (2005) Identification of noncanonical melanoma-associated T cell epitopes for cancer immunotherapy. J Immunol 174:6716\u20136724","journal-title":"J Immunol"},{"key":"1478_CR7","doi-asserted-by":"crossref","first-page":"e13406","DOI":"10.1371\/journal.pone.0013406","volume":"5","author":"Y Ye","year":"2010","unstructured":"Ye Y, Yin DT, Chen L et al (2010) Identification of Piwil2-like (PL2L) proteins that promote tumorigenesis. PLoS One 5:e13406. doi: 10.1371\/journal.pone.0013406","journal-title":"PLoS One"},{"key":"1478_CR8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/0929867053202188","volume":"12","author":"E Lazoura","year":"2005","unstructured":"Lazoura E, Apostolopoulos V (2005) Rational Peptide-based vaccine design for cancer immunotherapeutic applications. Curr Med Chem 12:629\u2013639","journal-title":"Curr Med Chem"},{"key":"1478_CR9","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.4049\/jimmunol.1000629","volume":"185","author":"DK Cole","year":"2010","unstructured":"Cole DK, Edwards ES, Wynn KK et al (2010) Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition. J Immunol 185:2600\u20132610. doi: 10.4049\/jimmunol.1000629","journal-title":"J Immunol"},{"key":"1478_CR10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-2478(99)00115-7","volume":"70","author":"B Tirosh","year":"1999","unstructured":"Tirosh B, el-Shami K, Vaisman N, Carmon L, Bar-Haim E, Vadai E, Feldman M, Fridkin M, Eisenbach L (1999) Immunogenicity of H-2\u00a0Kb-low affinity, high affinity, and covalently-bound peptides in anti-tumor vaccination. Immunol Lett 70:21\u201328","journal-title":"Immunol Lett"},{"key":"1478_CR11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/CJI.0b013e318248f2ae","volume":"35","author":"SH Tu","year":"2012","unstructured":"Tu SH, Huang HI, Lin SI et al (2012) A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo. J Immunother 35:235\u2013244. doi: 10.1097\/CJI.0b013e318248f2ae","journal-title":"J Immunother"},{"key":"1478_CR12","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.4049\/jimmunol.160.4.1750","volume":"160","author":"D Valmori","year":"1998","unstructured":"Valmori D, Fonteneau JF, Lizana CM et al (1998) Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A\/MART-1 immunodominant peptide analogues. J Immunol 160:1750\u20131758","journal-title":"J Immunol"},{"key":"1478_CR13","doi-asserted-by":"crossref","first-page":"7784","DOI":"10.1158\/0008-5472.CAN-09-1724","volume":"69","author":"MJ Stipdonk van","year":"2009","unstructured":"van Stipdonk MJ, Badia-Martinez D, Sluijter M, Offringa R, van Hall T, Achour A (2009) Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100. Cancer Res 69:7784\u20137792. doi: 10.1158\/0008-5472.CAN-09-1724","journal-title":"Cancer Res"},{"key":"1478_CR14","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0092-8674(93)90472-3","volume":"74","author":"J Ruppert","year":"1993","unstructured":"Ruppert J, Sidney J, Celis E, Kubo RT, Grey HM, Sette A (1993) Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929\u2013937","journal-title":"Cell"},{"key":"1478_CR15","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1002\/1521-4141(2000012)30:12<3411::AID-IMMU3411>3.0.CO;2-R","volume":"30","author":"S Tourdot","year":"2000","unstructured":"Tourdot S, Scardino A, Saloustrou E, Gross DA, Pascolo S, Cordopatis P, Lemonnier FA, Kosmatopoulos K (2000) A general strategy to enhance immunogenicity of low-affinity HLA-A2. 1-associated peptides: implication in the identification of cryptic tumor epitopes. Eur J Immunol 30:3411\u20133421. doi: 10.1002\/1521-4141(2000012)30:12<3411:AID-IMMU3411>3.0.CO;2-R","journal-title":"Eur J Immunol"},{"key":"1478_CR16","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.4049\/jimmunol.170.10.5188","volume":"170","author":"JS Gold","year":"2003","unstructured":"Gold JS, Ferrone CR, Guevara-Patino JA, Hawkins WG, Dyall R, Engelhorn ME, Wolchok JD, Lewis JJ, Houghton AN (2003) A single heteroclitic epitope determines cancer immunity after xenogeneic DNA immunization against a tumor differentiation antigen. J Immunol 170:5188\u20135194","journal-title":"J Immunol"},{"key":"1478_CR17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/1389203033487054","volume":"4","author":"PM Fischer","year":"2003","unstructured":"Fischer PM (2003) The design, synthesis and application of stereochemical and directional peptide isomers: a critical review. Curr Protein Pept Sci 4:339\u2013356","journal-title":"Curr Protein Pept Sci"},{"key":"1478_CR18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.canlet.2009.04.009","volume":"284","author":"YF Gao","year":"2009","unstructured":"Gao YF, Sun ZQ, Qi F, Qi YM, Zhai MX, Lou HP, Chen LX, Li YX, Wang XY (2009) Identification of a new broad-spectrum CD8\u00a0+\u00a0T cell epitope from over-expressed antigen COX-2 in esophageal carcinoma. Cancer Lett 284:55\u201361. doi: 10.1016\/j.canlet.2009.04.009","journal-title":"Cancer Lett"},{"key":"1478_CR19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4049\/jimmunol.181.1.146","volume":"181","author":"AD Gritzapis","year":"2008","unstructured":"Gritzapis AD, Voutsas IF, Lekka E, Tsavaris N, Missitzis I, Sotiropoulou P, Perez S, Papamichail M, Baxevanis CN (2008) Identification of a novel immunogenic HLA-A*0201-binding epitope of HER-2\/neu with potent antitumor properties. J Immunol 181:146\u2013154","journal-title":"J Immunol"},{"key":"1478_CR20","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1348-0421.2012.00470.x","volume":"56","author":"F Chen","year":"2012","unstructured":"Chen F, Zhai MX, Zhu YH, Qi YM, Zhai WJ, Gao YF (2012) In vitro and in vivo identification of a novel cytotoxic T lymphocyte epitope from Rv3425 of Mycobacterium tuberculosis. Microbiol Immunol 56:548\u2013553. doi: 10.1111\/j.1348-0421.2012.00470.x","journal-title":"Microbiol Immunol"},{"key":"1478_CR21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canlet.2011.07.004","volume":"311","author":"X Hui","year":"2011","unstructured":"Hui X, Chen H, Zhang S, Ma X, Wang X, Huang B (2011) Antitumor activities of recombinant human interferon (IFN)-lambda1 in vitro and in xenograft models in vivo for colon cancer. Cancer Lett 311:141\u2013151. doi: 10.1016\/j.canlet.2011.07.004","journal-title":"Cancer Lett"},{"key":"1478_CR22","first-page":"1850","volume":"9","author":"B Zhu","year":"2003","unstructured":"Zhu B, Chen Z, Cheng X et al (2003) Identification of HLA-A*0201-restricted cytotoxic T lymphocyte epitope from TRAG-3 antigen. Clin Cancer Res 9:1850\u20131857","journal-title":"Clin Cancer Res"},{"key":"1478_CR23","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1016\/j.vaccine.2012.05.077","volume":"30","author":"RN Wang","year":"2012","unstructured":"Wang RN, Wang YB, Geng JW, Guo DH, Liu F, Chen HY, Zhang HY, Cui BA, Wei ZY (2012) Enhancing immune responses to inactivated porcine parvovirus oil emulsion vaccine by co-inoculating porcine transfer factor in mice. Vaccine 30:5246\u20135252. doi: 10.1016\/j.vaccine.2012.05.077","journal-title":"Vaccine"},{"key":"1478_CR24","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/hep.22816","volume":"49","author":"FX Ding","year":"2009","unstructured":"Ding FX, Wang F, Lu YM, Li K, Wang KH, He XW, Sun SH (2009) Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus-related hepatocellular carcinoma. Hepatology 49:1492\u20131502. doi: 10.1002\/hep.22816","journal-title":"Hepatology"},{"key":"1478_CR25","author":"W Liu","year":"2011","unstructured":"Liu W, Zhai M, Wu Z, Qi Y, Wu Y, Dai C, Sun M, Li L, Gao Y (2011) Identification of a novel HLA-A2-restricted cytotoxic T lymphocyte epitope from cancer-testis antigen PLAC1 in breast cancer. Amino Acids. doi: 10.1007\/s00726-011-0966-3","journal-title":"Amino Acids"},{"key":"1478_CR26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.imlet.2011.06.009","volume":"140","author":"YH Zhu","year":"2011","unstructured":"Zhu YH, Gao YF, Chen F, Liu W, Zhai MX, Zhai WJ, Qi YM, Ye Y (2011) Identification of novel T cell epitopes from efflux pumps of Mycobacterium tuberculosis. Immunol Lett 140:68\u201373. doi: 10.1016\/j.imlet.2011.06.009","journal-title":"Immunol Lett"},{"key":"1478_CR27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1073\/pnas.0407677102","volume":"102","author":"R Tugyi","year":"2005","unstructured":"Tugyi R, Uray K, Ivan D, Fellinger E, Perkins A, Hudecz F (2005) Partial D-amino acid substitution: improved enzymatic stability and preserved Ab recognition of a MUC2 epitope peptide. Proc Natl Acad Sci USA 102:413\u2013418. doi: 10.1073\/pnas.0407677102","journal-title":"Proc Natl Acad Sci USA"},{"key":"1478_CR28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","volume":"50","author":"H Rammensee","year":"1999","unstructured":"Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213\u2013219","journal-title":"Immunogenetics"},{"key":"1478_CR29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.152.1.163","volume":"152","author":"KC Parker","year":"1994","unstructured":"Parker KC, Bednarek MA, Coligan JE (1994) Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152:163\u2013175","journal-title":"J Immunol"},{"key":"1478_CR30","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","volume":"12","author":"M Nielsen","year":"2003","unstructured":"Nielsen M, Lundegaard C, Worning P, Lauem\u00f8ller SL, Lamberth K, Buus S, Brunak S, Lund O (2003) Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 12:1007\u20131017","journal-title":"Protein Sci"},{"key":"1478_CR31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/1471-2105-8-424","volume":"8","author":"MV Larsen","year":"2007","unstructured":"Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, Nielsen M (2007) Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics 8:424","journal-title":"BMC Bioinformatics"},{"key":"1478_CR32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1515\/BC.2008.065","volume":"389","author":"J Schalich","year":"2008","unstructured":"Schalich J, Vytvytska O, Zauner W, Fischer MB, Buschle M, Aichinger G, Klade CS (2008) Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals. Biol Chem 389:551\u2013559","journal-title":"Biol Chem"},{"key":"1478_CR33","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-3083.2011.02606.x","volume":"74","author":"ZY Wu","year":"2011","unstructured":"Wu ZY, Gao YF, Wu YH, Liu W, Sun M, Zhai MX, Qi YM, Ye Y (2011) Identification of a novel CD8\u00a0+\u00a0T cell epitope derived from cancer-testis antigen MAGE-4 in oesophageal carcinoma. Scand J Immunol 74:561\u2013567. doi: 10.1111\/j.1365-3083.2011.02606.x","journal-title":"Scand J Immunol"},{"key":"1478_CR34","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.176.5.1453","volume":"176","author":"C Traversari","year":"1992","unstructured":"Traversari C, van der Bruggen P, Luescher IF, Lurquin C, Chomez P, Van Pel A, De Plaen E, Amar-Costesec A, Boon T (1992) A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 176:1453\u20131457","journal-title":"J Exp Med"},{"key":"1478_CR35","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1128\/JVI.80.10.4717-4728.2006","volume":"80","author":"N Goonetilleke","year":"2006","unstructured":"Goonetilleke N, Moore S, Dally L et al (2006) Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8\u00a0+\u00a0T-cell epitopes. J Virol 80:4717\u20134728. doi: 10.1128\/JVI.80.10.4717- 4728.2006","journal-title":"J Virol"},{"key":"1478_CR36","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/QAD.0b013e32833ce566","volume":"24","author":"D Salmon-Ceron","year":"2010","unstructured":"Salmon-Ceron D, Durier C, Desaint C et al (2010) Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial. AIDS 24:2211\u20132223. doi: 10.1097\/QAD.0b013e32833ce566","journal-title":"AIDS"},{"key":"1478_CR37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/erv.10.161","volume":"10","author":"NP Croft","year":"2011","unstructured":"Croft NP, Purcell AW (2011) Peptidomimetics: modifying peptides in the pursuit of better vaccines. Expert Rev Vaccines 10:211\u2013226. doi: 10.1586\/erv.10.161","journal-title":"Expert Rev Vaccines"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-013-1478-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-013-1478-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-013-1478-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T22:32:28Z","timestamp":1688509948000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-013-1478-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,29]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["1478"],"URL":"https:\/\/doi.org\/10.1007\/s00262-013-1478-7","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,29]]}}}